Black Rock Inc. Dare Bioscience, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 203,632 shares of DARE stock, worth $792,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares

203,632

Previous 396,098 48.59%

Holding current value

$792,128

Previous $194,000 64.43%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $0.61 $53,890 - $117,404	-192,466 Reduced 48.59%	203,632 $69,000
Q1 2024 May 10, 2024	SELL	$0.31 - $0.57 $2,029 - $3,731	-6,547 Reduced 1.63%	396,098 $194,000
Q4 2023 Feb 13, 2024	SELL	$0.29 - $0.53 $684 - $1,250	-2,360 Reduced 0.58%	402,645 $124,000
Q3 2023 Nov 13, 2023	SELL	$0.46 - $0.91 $5,086 - $10,061	-11,057 Reduced 2.66%	405,005 $186,000
Q2 2023 Aug 11, 2023	SELL	$0.91 - $1.05 $191,542 - $221,010	-210,486 Reduced 33.59%	416,062 $378,000
Q1 2023 May 12, 2023	SELL	$0.87 - $1.36 $78,258 - $122,334	-89,952 Reduced 12.55%	626,548 $651,000
Q4 2022 Feb 13, 2023	BUY	$0.82 - $12.6 $6,578 - $101,077	8,022 Added 1.13%	716,500 $594,000
Q3 2022 Nov 14, 2022	SELL	$1.04 - $12.48 $5,731 - $68,777	-5,511 Reduced 0.77%	708,478 $709,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.76 $105,235 - $197,037	111,953 Added 18.6%	713,989 $878,000
Q1 2022 May 12, 2022	BUY	$1.42 - $2.09 $332,625 - $489,567	234,243 Added 63.69%	602,036 $897,000
Q4 2021 Feb 10, 2022	BUY	$1.42 - $2.13 $347,996 - $521,994	245,068 Added 199.69%	367,793 $735,000
Q3 2021 Nov 09, 2021	SELL	$1.42 - $2.0 $17,287 - $24,348	-12,174 Reduced 9.02%	122,725 $205,000
Q2 2021 Aug 11, 2021	BUY	$1.21 - $1.89 $163,227 - $254,959	134,899 New	134,899 $255,000

Others Institutions Holding DARE

# of Institutions

Shares Held

7.13M

Call Options Held

Put Options Held

View Full List

About Dare Bioscience, Inc.

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $330M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

More about DARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account